Based on the observed salutary effect of NaBPC157 on bronchoconstriction induced by various spasmogens and the known close similarity between the used model and human conditions, a successful application of NaBPC157 is evident in treating various disorders connected with bronchoconstriction and/or disturbances of the respiratory tract
The companys validated results demonstrate its ability to help control blood glucose levels, assist in healthy weight management, and support overall metabolic wellness
Heres who might benefit most: People with insulin resistance or metabolic syndrome who have chronically elevated insulin levels that increase the production of artery-damaging cholesterol particles People with fatty liver disease and dyslipidemia (abnormal amount of fats in the blood) who need to lower inflammation and stress on the liver, bringing down high triglycerides and inhibiting production of artery-damaging cholesterol particles People whose blood work shows elevated levels of these biomarkers : ApoB : The total count of all plaque forming particles in the blood
Eli Lilly is studying the pill in a longer study in people who are overweight or have obesity to see if the weight loss continues
Was it the metabolism, or simply the abundance of free time
Body composition and cardiometabolic health across the menopause transition